Clinical Trial: The Effect of Erigeron Injection on Acute Cerebral Infarction Serum VEGF, MMP-9 and EPC Levels

Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional

Official Title: The Effect of Erigeron Injection on Acute Cerebral Infarction Serum VEGF, MMP-9 and EPC Levels

Brief Summary: To study the effects of Erigeron Injection on human serum VEGF, MMP-9 and EPC levels after acute cerebral infarction,test is made by random double-blind controlled.patients with acute cerebral infarction were divided randomly into erigeron injection+aspirin group,aspirin group,and health people. The main indexes are the serum level of VEGF, MMP-9 and EPC.The review is made by the reference to NIHSS and so on. So, Erigeron Injection have the function of promoting angiogenesis in multiple targets through this test.

Detailed Summary:

OBJECTIVE:

To study the effects of Erigeron Injection on human serum VEGF, MMP-9 and EPC levels after acute cerebral infarction.

METHOD:

40 patients with acute cerebral infarction(in accordance with the inclusion criteria) were divided randomly into erigeron injection+aspirin group,aspirin group,and 20 health people. Erigeron injection+aspirin group and aspirin group drew peripheral blood on the prior treatment,the posttreatment 1th, 3th and 7th day,and tested the level of VEGF, MMP-9 and EPC.Tested the health people one time.

Sponsor: Guangzhou University of Traditional Chinese Medicine

Current Primary Outcome: the serum level of VEGF,MMP-9 and EPC [ Time Frame: 0-7days ]

Original Primary Outcome: Same as current

Current Secondary Outcome: National Institute of Health of stroke scale [ Time Frame: 0-7days ]

Original Secondary Outcome: Same as current

Information By: Guangzhou University of Traditional Chinese Medicine

Dates:
Date Received: August 19, 2013
Date Started: August 2013
Date Completion: March 2014
Last Updated: August 19, 2013
Last Verified: August 2013